100 related articles for article (PubMed ID: 26171920)
21. Novel PNLIPRP3 and DOCK8 gene expression and prognostic implications of DNA loss on chromosome 10q25.3 in hepatocellular carcinoma.
Saelee P; Wongkham S; Puapairoj A; Khuntikeo N; Petmitr S; Chariyalertsak S; Sumethchotimaytha W; Karalak A
Asian Pac J Cancer Prev; 2009; 10(3):501-6. PubMed ID: 19640199
[TBL] [Abstract][Full Text] [Related]
22. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
[TBL] [Abstract][Full Text] [Related]
23. Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.
Yamada D; Kobayashi S; Yamamoto H; Tomimaru Y; Noda T; Uemura M; Wada H; Marubashi S; Eguchi H; Tanemura M; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S355-64. PubMed ID: 21607773
[TBL] [Abstract][Full Text] [Related]
24. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma.
Wang C; Ren T; Wang K; Zhang S; Liu S; Chen H; Yang P
Sci China Life Sci; 2017 Sep; 60(9):1047-1050. PubMed ID: 28547580
[No Abstract] [Full Text] [Related]
25. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
[TBL] [Abstract][Full Text] [Related]
26. Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study.
Barbu V; Bonnand AM; Hillaire S; Coste T; Chazouilleres O; Gugenheim J; Boucher E; Poupon R; Poupon RE
Hepatology; 1997 Nov; 26(5):1171-5. PubMed ID: 9362358
[TBL] [Abstract][Full Text] [Related]
27. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
28. Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
Nagao T; Ishida Y; Kondo Y
Mod Pathol; 1996 Feb; 9(2):99-104. PubMed ID: 8657727
[TBL] [Abstract][Full Text] [Related]
29. Liver cancer: A model of fibrolamellar carcinoma.
Patman G
Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):672. PubMed ID: 26503883
[No Abstract] [Full Text] [Related]
30. Heterogeneity Among Liver Cancer--A Hurdle to Optimizing Therapy.
Birkbak NJ; Andersen JB
Gastroenterology; 2016 Apr; 150(4):818-21. PubMed ID: 26924088
[No Abstract] [Full Text] [Related]
31. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
32. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.
Ma H; Liang X; Chen Y; Pan K; Sun J; Wang H; Wang Q; Li Y; Zhao J; Li J; Chen M; Xia J
Int J Cancer; 2011 Feb; 128(4):771-7. PubMed ID: 20473897
[TBL] [Abstract][Full Text] [Related]
34. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms: A Potential Diagnostic Pitfall.
Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
[TBL] [Abstract][Full Text] [Related]
35. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.
El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316
[TBL] [Abstract][Full Text] [Related]
36. dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling.
Ouyang J; Sun Y; Li W; Zhang W; Wang D; Liu X; Lin Y; Lian B; Xie L
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2688-95. PubMed ID: 26940364
[TBL] [Abstract][Full Text] [Related]
37. [Expression of metastasis suppressor gene nm23 in human hepatocellular carcinoma].
Chen X; Dai Y; Yang J
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):76-8. PubMed ID: 9206208
[TBL] [Abstract][Full Text] [Related]
38. EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy.
Tang J; Ou J; Xu C; Yi C; Xue F; Xu L; Lai F; Tang J; Li S; Kang T; Ding W; Wang B
Oncol Rep; 2017 Oct; 38(4):2251-2258. PubMed ID: 28765910
[TBL] [Abstract][Full Text] [Related]
39. [The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis].
Wu F; Liang YQ; Huang ZM
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):203-6. PubMed ID: 19335984
[TBL] [Abstract][Full Text] [Related]
40. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
